Efficacy, Safety, and Patient-Reported Outcomes in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Brodalumab for 5 Years in a Long-Term, Open-Label, Phase II Study

BACKGROUND: Chronic inflammatory diseases such as psoriasis require treatment options that maintain efficacy and tolerability during extended treatment. OBJECTIVE: The aim of the study was to assess the long-term efficacy and safety of brodalumab, a fully human anti-interleukin-17 receptor A monoclo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Clin Dermatol
Main Authors: Lebwohl, Mark G., Blauvelt, Andrew, Menter, Alan, Papp, Kim A., Guenthner, Scott, Pillai, Radhakrishnan, Israel, Robert J., Jacobson, Abby
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2019
Assuntos:
Original Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6872506/
https://ncbi.nlm.nih.gov/pubmed/31493163
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40257-019-00466-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados